Literature DB >> 3956567

Single dose prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic study.

A Rubenson, A Rosetzsky.   

Abstract

Plasma metronidazole was measured following a single intravenous dose of 20 mg/kg (Flagyl 5 mg/ml) in 12 infants less than 1 year of age undergoing abdominal surgery. In all patients sufficient plasma concentrations, well above the MIC values for anaerobic bacteria, were found for at least 16 h. A prolonged half-life was demonstrated in the group less than 8 weeks of age (t1/2/18.4 h). The group over 8 weeks of age demonstrated a t1/2 comparable to that seen in adults (t1/2 7 h).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956567     DOI: 10.1007/bf00635904

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.

Authors:  H Hof; V Sticht-Groh; K M Müller
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

2.  Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose.

Authors:  G W Houghton; P S Thorne; J Smith; R Templeton; J Collier
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

3.  Comparative pharmacokinetic studies of ornidazole and metronidazole in man.

Authors:  D E Schwartz; F Jeunet
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

4.  Pharmacokinetics and tissue distribution of metronidazole in the new born infant.

Authors:  E Jager-Roman; P E Doyle; J Baird-Lambert; M Cvejic; N Buchanan
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

5.  Single and multiple dose cotrimoxazole and metronidazole in colorectal surgery.

Authors:  A F Higgins; A Lewis; P Noone; M L Hole
Journal:  Br J Surg       Date:  1980-02       Impact factor: 6.939

6.  Disposition kinetics of metronidazole in children.

Authors:  I Amon; K Amon; H Scharp; G Franke; F Nagel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  A randomized evaluation of single dose chemoprophylaxis in elective colorectal surgery--a comparison between metronidazole and doxycycline.

Authors:  J H Solhaug; L Bergman; F Kylberg
Journal:  Ann Clin Res       Date:  1983

8.  In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species.

Authors:  I Haller
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

9.  A new approach to antibiotic therapy in colon surgery based on bioassay tissue concentrations.

Authors:  S Chou; G K Richards; R A Brown
Journal:  Can J Surg       Date:  1982-09       Impact factor: 2.089

10.  The activity of four antimicrobial agents. Including three nitroimidazole compounds, against Bacteroides sp.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

View more
  4 in total

1.  The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst.

Authors:  Robin E Pearce; Michael Cohen-Wolkowiez; Mario R Sampson; Gregory L Kearns
Journal:  Drug Metab Dispos       Date:  2013-06-27       Impact factor: 3.922

Review 2.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 4.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.